The other occurs primarily during adulthood, harbors additional oncogenic alterations including CDKN2A homozygous deletion and ATRX mutation, follows a more aggressive clinical course, and is epigenetically diverse, with most tumors aligning with either HGAP or various subclasses of IDH wild-type glioblastoma. This evidence concerns the gene CDKN2A and glioblastoma.